Cervical Cancer occurs when abnormal cancer cells develop in the cervix due to exposure to the human papillomavirus (HPV), however not all types of HPV cause cervical cancer. Cervical cancer is the second most common type of cancer in women and the most greatly affects the age groups 35-39 and 60-64. It is frequently found in early stages through the use of pap test. Cervical cancer is commonly treated with chemotherapy, radiation, and surgery to remove pelvic lymph nodes with or without the removal of the ovaries and fallopian tubes. In the most severe cases, hysterectomies may be necessary. Many believe that the HPV vaccine protects against the two types of HPV that cause cervical cancer. In stage 1B2 of cervical cancer, the growths can typically be seen without a microscope yet the cancer has not spread past the tissues of the cervix. At this point, the cancer is larger than 4 cm across. Once diagnosed with 1B2, chemoradiation (a combination of chemotherapy and radiotherapy) may be the best route of therapy.
Stage Ib2 Cervical Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage Ib2 Cervical Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 373 products for the study of Stage Ib2 Cervical Cancer that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.